{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T23:12:43Z","timestamp":1793661163777,"version":"4.5.1"},"reference-count":37,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2014,10,2]],"date-time":"2014-10-02T00:00:00Z","timestamp":1412208000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0003212","type":"journal-article","created":{"date-parts":[[2014,10,2]],"date-time":"2014-10-02T18:06:15Z","timestamp":1412273175000},"page":"e3212","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":44,"title":["Melarsoprol Sensitivity Profile of Trypanosoma brucei gambiense Isolates from Cured and Relapsed Sleeping Sickness Patients from the Democratic Republic of the Congo"],"prefix":"10.1371","volume":"8","author":[{"given":"Patient","family":"Pyana Pati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"Van Reet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieudonn\u00e9","family":"Mumba Ngoyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ipos","family":"Ngay Lukusa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stomy","family":"Karhemere Bin Shamamba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"B\u00fcscher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,10,2]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"e1007","DOI":"10.1371\/journal.pntd.0001007","article-title":"The human African trypanosomiasis control and surveillance programme of the World Health Organization 2000\u20132009: the way forward","volume":"5","author":"PP Simarro","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"195040","DOI":"10.1155\/2009\/195040","article-title":"Chemotherapy of human African trypanosomiasis","volume":"2009","author":"CJ Bacchi","year":"2009","journal-title":"Interdiscip Perspect Infect Dis"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1017\/S0031182012000169","article-title":"Update on field use of the available drugs for the chemotherapy of human African trypanosomiasis","volume":"139","author":"PP Simarro","year":"2012","journal-title":"Parasitology"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0140-6736(09)61117-X","article-title":"Nifurtimox-eflornithine combination therapy for second-stage African <italic>Trypanosoma brucei gambiense<\/italic> trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial","volume":"374","author":"G Priotto","year":"2009","journal-title":"Lancet"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1046\/j.1365-3156.2001.00724.x","article-title":"The situation of sleeping sickness in Angola: a calamity","volume":"6","author":"A Stanghellini","year":"2001","journal-title":"Trop Med Int Health"},{"key":"ref6","first-page":"171","article-title":"Echecs th\u00e9rapeutiques du m\u00e9larsoprol parmi des patients trait\u00e9s au stade tardif de trypanosomose humaine africaine \u00e0 <italic>T. b. gambiense<\/italic> en Ouganda","volume":"92","author":"D Legros","year":"1999","journal-title":"Bull Soc Pathol Exot Fil"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1046\/j.1365-3156.2001.00775.x","article-title":"The phenomenon of treatment failures in human African trypanosomiasis","volume":"6","author":"R Brun","year":"2001","journal-title":"Trop Med Int Health"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1086\/649917","article-title":"How to shorten patient follow-up after treatment for <italic>Trypanosoma brucei gambiense<\/italic> sleeping sickness?","volume":"201","author":"D Mumba Ngoyi","year":"2010","journal-title":"J Infect Dis"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.actatropica.2007.07.007","article-title":"Genotypic and phenotypic characterization of <italic>Trypanosoma brucei gambiense<\/italic> isolates from Ibba, South Sudan, an area of high melarsoprol treatment failure","volume":"104","author":"N Maina","year":"2007","journal-title":"Acta Trop"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"966","DOI":"10.3201\/eid1406.071266","article-title":"High failure rates of melarsoprol for sleeping sickness, Democratic Republic of Congo","volume":"14","author":"J Robays","year":"2008","journal-title":"Em Inf Dis"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1046\/j.1365-3156.2001.00712.x","article-title":"Melarsoprol refractory <italic>T. b. gambiense<\/italic> from Omugo, north-western Uganda","volume":"6","author":"E Matovu","year":"2001","journal-title":"Trop Med Int Health"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1046\/j.1365-3156.2001.00725.x","article-title":"Pharmacokinetic investigations in patients from northern Angola refractory to melarsoprol treatment","volume":"6","author":"C Burri","year":"2001","journal-title":"Trop Med Int Health"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1111\/j.1365-3156.2007.01918.x","article-title":"Detection of mutant P2 adenosine transporter (TbAT1) gene in <italic>Trypanosoma brucei gambiense<\/italic> isolates from northwest Uganda using allele-specific polymerase chain reaction","volume":"12","author":"B Nerima","year":"2007","journal-title":"Trop Med Int Health"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1128\/EC.2.5.1003-1008.2003","article-title":"Mechanisms of arsenical and diamidine uptake and resistance in <italic>Trypanosoma brucei<\/italic>","volume":"2","author":"E Matovu","year":"2003","journal-title":"Eukaryot Cell"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0166-6851(01)00332-2","article-title":"Genetic variants of the <italic>TbAT1<\/italic> adenosine transporter from African trypanosomes in relapse infections following melarsoprol therapy","volume":"117","author":"E Matovu","year":"2001","journal-title":"Mol Biochem Parasitol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"e486","DOI":"10.1371\/journal.pntd.0000486","article-title":"Bioluminescent imaging of <italic>Trypanosoma brucei<\/italic> shows preferential testis dissemination which may hamper drug efficacy in sleeping sickness patients","volume":"3","author":"F Claes","year":"2009","journal-title":"PLoS Negl Trop Dis"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1126\/science.285.5425.242","article-title":"A nucleoside transporter from <italic>Trypanosoma brucei<\/italic> involved in drug resistance","volume":"285","author":"P M\u00e4ser","year":"1999","journal-title":"Science"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1124\/mol.106.031351","article-title":"Loss of the high-affinity pentamidine transporter is responsible for high levels of cross-resistance between arsenical and diamine drugs in African trypanosomes","volume":"71","author":"DJ Bridges","year":"2007","journal-title":"Mol Pharmacol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"10996","DOI":"10.1073\/pnas.1202885109","article-title":"Aquaglyceroporin 2 controls susceptibility to melarsoprol and pentamidine in African trypanosomes","volume":"109","author":"N Baker","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"e2475","DOI":"10.1371\/journal.pntd.0002475","article-title":"Aquaporin 2 mutations in <italic>Trypanosoma brucei gambiense<\/italic> field isolates concur with decreased susceptibility to pentamidine and melarsoprol","volume":"7","author":"FE Graf","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"133","DOI":"10.4269\/ajtmh.1992.47.133","article-title":"The impact of human immunodeficiency virus infection on the epidemiology and treatment of <italic>Trypanosoma brucei gambiense<\/italic> sleeping sickness in Nioki, Zaire","volume":"47","author":"J P\u00e9pin","year":"1992","journal-title":"Am J Trop Med Hyg"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0035-9203(02)90380-9","article-title":"<italic>Trypanosoma brucei gambiense<\/italic> African trypanosomiasis: differences between men and women in severity of disease and response to treatment","volume":"96","author":"J P\u00e9pin","year":"2002","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0035-9203(99)90151-7","article-title":"Risk factors for treatment failure after melarsoprol for <italic>Trypanosoma brucei gambiense<\/italic> trypanosomiasis in Uganda","volume":"93","author":"D Legros","year":"1999","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1093\/jac\/dkt442","article-title":"<italic>Trypanosoma brucei<\/italic> aquaglyceroporin 2 is a high-affinity transporter for pentamidine and melaminophenyl arsenic drugs and the main genetic determinant of resistance to these drugs","volume":"69","author":"JC Munday","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"e1025","DOI":"10.1371\/journal.pntd.0001025","article-title":"Isolation of <italic>Trypanosoma brucei gambiense<\/italic> from cured and relapsed sleeping sickness patients and adaptation to laboratory mice","volume":"5","author":"PP Pyana","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"ref26","article-title":"A panel of <italic>Trypanosoma brucei<\/italic> strains tagged with blue and red shifted luciferases for bioluminescent imaging in murine infection models","author":"N Van Reet","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"e471","DOI":"10.1371\/journal.pntd.0000471","article-title":"Improved models of mini anion exchange centrifugation technique (mAECT) and modified single centrifugation (MSC) for sleeping sickness diagnosis and staging","volume":"3","author":"P B\u00fcscher","year":"2009","journal-title":"PLoS Negl Trop Dis"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/0014-4894(70)90120-7","article-title":"Isolation of salivarian trypanosomes from man and other mammals using DEAE-cellulose","volume":"28","author":"SM Lanham","year":"1970","journal-title":"Exp Parasitol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"3887","DOI":"10.1093\/nar\/22.19.3887","article-title":"Gene expression mediated by bacteriophage T3 and T7 RNA polymerase in transgenic trypanosomes","volume":"22","author":"E Wirtz","year":"1994","journal-title":"Nucleic Acids Res"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1365-3156.2005.01545.x","article-title":"Drug-resistance of <italic>Trypanosoma b. rhodesiense<\/italic> isolates from Tanzania","volume":"11","author":"SN Kibona","year":"2006","journal-title":"Trop Med Int Health"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"e509","DOI":"10.1371\/journal.pntd.0000509","article-title":"Murine models for <italic>Trypanosoma brucei gambiense<\/italic> disease progression-from silent to chronic infections and early brain tropism","volume":"3","author":"C Giroud","year":"2009","journal-title":"PLoS Negl Trop Dis"},{"key":"ref32","first-page":"465","article-title":"Historique de la lutte contre la maladie du sommeil au Congo","volume":"51","author":"J Burke","year":"1971","journal-title":"Ann Soc Belg M\u00e9d Trop"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1046\/j.1365-3156.2001.00753.x","article-title":"Trypanosomiase humaine africaine: historique de la th\u00e9rapeutique et ses \u00e9checs","volume":"6","author":"G Ollivier","year":"2001","journal-title":"Trop Med Int Health"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.exppara.2005.04.001","article-title":"<italic>Trypanosoma brucei<\/italic> s.<italic>l<\/italic>.: Characterisation of stocks from Central Africa by PCR analysis of mobile genetic elements","volume":"110","author":"G Simo","year":"2005","journal-title":"Exp Parasitol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1086\/588668","article-title":"Novel markers for treatment outcome in late stage <italic>T.b. gambiense<\/italic> trypanosomiasis","volume":"47","author":"V Lejon","year":"2008","journal-title":"Clin Infect Dis"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S0140-6736(04)16940-7","article-title":"Efficacy of 10-day melarsoprol schedule 2 years after treatment for late-stage gambiense sleeping sickness","volume":"364","author":"C Schmid","year":"2004","journal-title":"Lancet"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"777","DOI":"10.2471\/BLT.05.028399","article-title":"Treatment outcomes and risk factors for relapse in patients with early-stage human African trypanosomiasis (HAT) in the Republic of the Congo","volume":"84","author":"M Balasegaram","year":"2006","journal-title":"Bull World Health Organ"}],"container-title":["PLoS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0003212","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T15:01:46Z","timestamp":1589036506000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0003212"}},"subtitle":[],"editor":[{"given":"Joseph Mathu","family":"Ndung'u","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,10,2]]},"references-count":37,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2014,10,2]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0003212","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,2]]}}}